Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma.

Alexander Chehrazi-RaffleLuis MezaMarice AlcantaraNazli DizmanPaulo BergerotNicholas SalgiaJoAnn HsuNora RuelSabrina SalgiaJasnoor MalhotraEwa KarczewskaMarcin KortylewskiSumanta Kumar Pal

Published in: Journal for immunotherapy of cancer (2021)

For patients receiving VEGF-TKI or ICI therapy, distinct plasma cytokines were associated with clinical benefit. Our findings support additional investigation into plasma cytokines as biomarkers in metastatic RCC.

Keyphrases

metastatic renal cell carcinoma
small cell lung cancer
squamous cell carcinoma
endothelial cells
tyrosine kinase
vascular endothelial growth factor
stem cells
advanced non small cell lung cancer
bone marrow
cell therapy